{
  "id": 17933222,
  "title": "Central African Republic: U.S. FDA Approves First Generic Injectable Lenacapavir for HIV Prevention",
  "url": "https://urgent.news/2026/11/03/central-african-republic-u-s-fda-approves-first-generic-injectable",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-03T05:33:38.000Z",
  "source": {
    "name": "AllAfrica Health",
    "slug": "allafrica-health",
    "url": "https://allafrica.com/stories/202611030111.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "[UNITAID] The U.S. Food and Drug Administration (FDA) has approved the first generic long-acting injectable for HIV prevention, just 16 months after the approval of the originator product. A novel regulatory strategy resulted in one of the fastest timelines to approval for a major HIV innovation to date. Developed by Dr. Reddy's Laboratories with financial, technical, and regulatory support from…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Health Policy Watch",
        "title": "FDA Approves First Generic of HIV Prevention Drug, Lenacapavir",
        "url": "https://urgent.news/2026/11/02/fda-approves-first-generic-of-hiv-prevention-drug-lenacapavir",
        "published": "2026-11-02T14:08:29.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}